• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Private Equity Firm Acquires Pharmacy Automation Provider Capsa Healthcare

by Fred Pennic 09/12/2017 Leave a Comment

Private Equity Firm Acquires Pharmacy Automation Provider Capsa Healthcare

Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm has acquired Capsa Healthcare, a provider of mobile workstations, medication management products, and pharmacy automation solutions for healthcare settings. Financial terms of the acquisition were not disclosed.

Formed through the integration of Capsa Solutions, Rubbermaid Healthcare, and Kirby Lester, Capsa Healthcare develops and manufactures Point-of-Care Workstations, Medication Management Solutions, and Pharmacy Automation Systems that elevate their customers’ performance by understanding their challenges and offering high-quality, integrated solutions.

The Company’s workflow solutions increase efficiency for over 3,000 customers, including leading health systems, senior care communities and major retail and institutional pharmacies.  Capsa is headquartered in Portland, OR and has additional production facilities in Columbus, OH and Agua Prieta, Mexico.

 

As part of the acquisition, Capsa Healthcare led by CEO Andrew Sherrill will acquire a meaningful ownership stake in Levine Leichtman Capital Partners. “My team and I are very excited to partner with LLCP as Capsa seeks to enhance its market-leading position across the healthcare ecosystem. LLCP’s experience across sectors including highly-engineered products and healthcare services – the intersection of which Capsa is situated – as well as LLCP’s operational and deal origination resources, will be critical to the continued growth of the Company,” said CEO Andrew Sherrill in a statement. 

Tagged With: Capsa Healthcare, Healthcare Mergers & Acquisitions, Mobile Medication, Mobile Medication Carts, Pharmacy Automation

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |